Related Experiment Video
Updated: Jul 18, 2026

A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences
Published on: September 4, 2019
ALLHAT, or the soft science of the secondary end point
1Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA. fmesserli@aol.com
Insights
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial found no difference in coronary heart disease between chlorthalidone, lisinopril, and amlodipine. Conclusions favoring thiazide diuretics were based on secondary outcomes, not primary data.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a significant study in cardiovascular disease research.
- Previous interpretations of ALLHAT have influenced hypertension treatment guidelines, notably the Seventh Report of the Joint National Committee (JNC 7).
Purpose of the Study:
- To critically evaluate the conclusions drawn from the ALLHAT trial regarding antihypertensive drug classes.
- To assess the validity of prioritizing thiazide diuretics for first-line hypertension therapy based on ALLHAT's findings.
Main Methods:
- Analysis of primary and secondary end points from the ALLHAT trial.
- Review of the evidence used to support recommendations in hypertension treatment guidelines.
Main Results:
- The primary end point, coronary heart disease, showed no significant difference between chlorthalidone, lisinopril, and amlodipine groups.
- Conclusions favoring thiazide diuretics were based on secondary end points and cost-effectiveness analyses, not primary outcome data.
Conclusions:
- The reliance on secondary end points in ALLHAT for major conclusions is questionable.
- Thiazide diuretics remain important in hypertension management, but should not be exclusively preferred based on this interpretation of ALLHAT.
- Further consideration of 'soft data' in clinical trial interpretation is warranted for evidence-based hypertension therapy.
Abstract:
The recent Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) showed that the primary end point, coronary heart disease, was identical in the chlorthalidone, lisinopril, and amlodipine groups. Yet the major conclusion of this trial was that thiazide diuretics are superior in preventing 1 or more major forms of cardiovascular disease and should be preferred for first-line antihypertensive therapy. This conclusion was based solely on an analysis of secondary end points and cost. As evidenced by the dictum to "use thiazides for most patients with uncomplicated hypertension" in the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, this interpretation of ALLHAT broadly adumbrated these guidelines. Although diuretics will rightfully remain a cornerstone in antihypertensive therapy, we should remember (as we were told by the ALLHAT investigators) that secondary end points are "soft data" that should not form a basis for main conclusions or lead to a labeling of a drug class as preferred.
Related Concept Videos
Regression Toward the Mean
Secondary Healthcare System
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting the...
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

